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Zygotic genome activation (ZGA) is a nuclear reprogramming event that transforms the genome from
transcriptional quiescence at fertilization to robust transcriptional activity shortly thereafter. The ensuing
gene expression profile in the cleavage-stage embryo establishes totipotency and is required for further
development. Although little is known about the molecular basis of ZGA, oocyte-derived mRNAs and
proteins that alter chromatin structure are likely crucial. To test this hypothesis, we generated a
maternal-effect mutation of Brg1, which encodes a catalytic subunit of SWI/SNF-related complexes, utilizing
Cre-loxP gene targeting. In conditional-mutant females, BRG1-depleted oocytes completed meiosis and were
fertilized. However, embryos conceived from BRG1-depleted eggs exhibited a ZGA phenotype including
two-cell arrest and reduced transcription for ∼30% of expressed genes. Genes involved in transcription, RNA
processing, and cell cycle regulation were particularly affected. The early embryonic arrest is not a
consequence of a defective oocyte because depleting maternal BRG1 after oocyte development is complete by
RNA interference (RNAi) also resulted in two-cell arrest. To our knowledge, Brg1 is the first gene required for
ZGA in mammals. Depletion of maternal BRG1 did not affect global levels of histone acetylation, whereas
dimethyl-H3K4 levels were reduced. These data provide a framework for understanding the mechanism of
ZGA.
[Keywords: Two-cell embryo; BRG1; SWI/SNF; maternal-effect mutation; transcriptional regulation; zygotic
genome activation]
Supplemental material is available at http://www.genesdev.org.
Received March 28, 2006; revised version accepted April 26, 2006.
In Drosophila and Xenopus, mRNAs stockpiled in the
oocyte are stable after fertilization and regulate many
aspects of embryonic development (Wolpert et al. 2002).
Conversely, in mammals, oocyte-derived mRNAs are de-
graded shortly after fertilization and cannot direct more
than the first few cell divisions (Thompson et al. 1998).
Therefore, zygotic genome activation (ZGA) must occur
very early during mammalian development. In the
mouse, a minor burst of ZGA toward the end of the
one-cell stage is followed by a major burst during the
two-cell stage (Latham et al. 1992; Vernet et al. 1992;
Aoki et al. 1997; Thompson et al. 1998; Schultz 2002). In
a variety of other mammals, including humans, the em-
bryonic genome is activated in a similar stepwise man-
ner at the four- to eight-cell stage or the eight- to 16-cell
stage (Telford et al. 1990; Kanka 2003). ZGA is required
for continued development because mRNAs common to
the oocyte and embryo (e.g., genes involved in the ma-
ternal-to-zygotic transition and housekeeping genes) are
replenished and many genes not transcribed in the oo-
cyte are expressed for the first time. The outcome of
ZGA is a novel gene expression profile that establishes
the totipotent state of each blastomere in the cleavage-
stage embryo. This step is a prerequisite for future cell
lineage commitments and differentiation events that un-
derlie pattern formation and organogenesis.
Changes in chromatin structure are thought to play an
important role in reprogramming gene expression during
ZGA (Schultz and Worrad 1995; Thompson et al. 1998;
Kanka 2003). For example, an apparent increase in his-
tone acetylation accompanies the one-to-two-cell tran-
sition in the mouse (Worrad et al. 1995; Stein et al. 1997;
Sarmento et al. 2004). However, it remains unclear
whether this epigenetic modification is a causative fac-
tor or is merely consequential to acquisition of transcrip-
tional competence. Indeed, very little is known about
the molecular basis of ZGA because mutations that per-
turb the process have yet to be identified. One potential
problem may be that genetic redundancy has prevented
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the appearance of ZGA phenotypes. For instance, there
are more than a dozen histone acetyltransferases (HATs)
that modify many of the same amino acids. Another po-
tential problem is that maternally derived proteins,
which are synthesized in the oocyte and regulate ZGA,
are not perturbed by conventional mutagenesis strate-
gies. When an intercross is performed, maternally de-
rived proteins could potentially support development to
implantation (perhaps explaining why null mutations
rarely, if ever, result in early cleavage-stage lethality)
(http://www.informatics.jax.org). If the mutation confers
homozygous lethality, then mutant females cannot be
recovered and bred to evaluate the role of the maternal
factor in the early embryo.
Mammalian SWI/SNF-related chromatin remodeling
complexes regulate transcription and are good candi-
dates for being involved in ZGA. They have a molecular
mass of ∼1 MDa and consist of approximately nine sub-
units, although their composition can vary in different
cell types and tissues (Wang et al. 1996a,b; Kingston and
Narlikar 1999; Olave et al. 2002; Smith et al. 2003;
Mohrmann and Verrijzer 2005). None of these complexes
bind to DNA in a sequence-specific manner but rather
are recruited to promoters of target genes by sequence-
specific transcription factors (Peterson and Workman
2000; Bultman et al. 2005). Once recruited, the BRG1
catalytic subunit exhibits DNA-dependent ATPase ac-
tivity, and the energy derived from ATP hydrolysis alters
the conformation and position of nucleosomes (Kingston
and Narlikar 1999). DNA–histone contacts are broken,
and histone octamers can be slid several hundred base
pairs upstream or downstream (Bazett-Jones et al. 1999;
Whitehouse et al. 1999). As a result of this nucleosome
disruption activity, promoters are made accessible to the
RNA polymerase II holoenzyme so transcription can be
initiated.
We previously demonstrated that Brg1 is essential in
the mouse as null homozygotes die at the blastocyst
stage (Bultman et al. 2000). Several other subunits of
SWI/SNF-related complexes, often referred to as BRG1-
associated factors (BAFs), have also been knocked out
and confer peri-implantation lethality as well (Klochen-
dler-Yeivin et al. 2000; Roberts et al. 2000; Guidi et al.
2001; Kim et al. 2001; Lickert et al. 2004; Wang et al.
2004). However, Brg1 might be required before the blas-
tocyst stage because it is expressed in oocytes (LeGouy
et al. 1998; Bultman et al. 2000), and maternally derived
BRG1 protein, stockpiled in oocytes of heterozygous fe-
males, may mask an even earlier phenotype in null ho-
mozygotes.
Here, we describe an oocyte-specific Brg1 mutation
generated by Cre-loxP gene targeting. In conditional mu-
tant females, BRG1-depleted oocytes are meiotically
competent and capable of being fertilized, but embryos
conceived from depleted eggs exhibit a ZGA defect. De-
velopment of these embryos is arrested at the two- to
four-cell stage, and transcriptional activity is reduced for
∼30% of genes expressed at this stage, with genes in-
volved in transcription, RNA processing, and cell cycle
regulation being particularly affected. The cleavage-stage
arrest is not simply a consequence of a defective oocyte
because depletion of maternal BRG1 subsequent to nor-
mal oocyte development (through RNA interference
[RNAi]) also results in two- to four-cell arrest. Rather,
examination of covalent histone modifications in mater-
nally depleted embryos implicate a role for maternal
BRG1 in establishing chromatin structure and transcrip-
tional competence at the two-cell stage.
Results
Reduced fertility of Brg1Zp3-Cre conditional
mutant females
To generate an oocyte-specific Brg1 mutation, we
crossed previously described knockout and transgenic
mouse stocks (Lewandoski et al. 1997; Sumi-Ichinose
et al. 1997; Bultman et al. 2000). The resulting
Brg1Zp3-Cre stock had a genotype of Brg1null/floxed,
TgZp3-Cre. Brg1null/floxed mice have a null allele (Brg1null)
balanced with a functionally normal floxed allele
(Brgfloxed) that is converted to a recombined null allele
(Brg1floxed) in cells expressing Cre (Gebuhr et al. 2003).
The zona pellucida 3-Cre transgene (TgZp3-Cre) is ex-
pressed only in oocytes and contained a nuclear localiza-
tion signal (NLS) to increase the efficiency of Cre-medi-
ated recombination (Lewandoski et al. 1997). Therefore,
Brg1Zp3-Cre conditional mutant females were heterozy-
gous for the Brg1-null mutation in all tissues except the
germline, which had a homozygous null genotype.
Brg1Zp3-Cre females were bred to wild-type males to
test their fertility. Both the number of litters born and
litter sizes were markedly reduced compared with con-
trol females having either a wild-type or heterozygous
germline (Table 1). To investigate a potential defect in
female germ cell development, we analyzed hematoxylin
and eosin (H&E)-stained sections of ovaries from control
and conditional mutant females. We identified primary
follicles, secondary follicles, and corpora lutea in both
genotypic classes and did not observe any histological
defects in conditional mutant ovary sections (Fig. 1A,B).
In addition, we recovered a normal number of unfertil-
ized eggs from superovulated, unmated Brg1Zp3-Cre fe-
males (Fig. 1C). Both the size and morphology (including
extrusion of the first polar body and metaphase II arrest)
of these mutant eggs was similar to controls (Fig. 1D).











+/+ 5 5.8 ± 0.3 9.8 ± 2.9
+/− 5 5.3 ± 0.5 6.5 ± 2.5
−/− 6 1.3 ± 0.3 1.5 ± 0.3
a(+/+) Brg1+/floxed no transgene; (+/−) Brg1+/floxed with Zp3-Cre
transgene; (−/−) Brg1null/floxed with Zp3-Cre transgene.
bMated with wild-type males over a 4-mo period.
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Characterization of Cre-mediated recombination
PCR genotyping was performed to evaluate the specific-
ity and efficiency of Cre-mediated recombination at the
Brg1 locus. The floxed allele was amplified from tail
samples, whereas the floxed allele could not be de-
tected (Supplementary Fig. S1). These results were an-
ticipated because the Zp3-Cre transgene is not expressed
in somatic tissues (Lewandoski et al. 1997). Also as ex-
pected, the floxed allele was amplified in eggs from con-
trol mice lacking a Zp3-Cre transgene, whereas the
floxed allele was amplified in eggs from Brg1Zp3-Cre fe-
males carrying the Zp3-Cre transgene (Supplementary
Fig. S1). Brg1+/floxed, TgZp3-Cre carrier females were bred
to wild-type males and transmitted the floxed allele
but not the floxed allele to 17 progeny (Supplementary
Fig. S1; data not shown), indicating that Cre-mediated
recombination was highly efficient.
The timing of recombination in the female germline is
also a potentially important factor because Brg1 is ex-
pressed at the same time as Zp3-Cre during the oocyte
growth phase (Pan et al. 2005). Considering that Brg1
transcription might have occurred in the oocyte prior to
the floxed-to-floxed recombination event, we analyzed
Brg1 expression in ovulated, unfertilized eggs. We per-
formed RT–PCR and detected Brg1 mRNA at robust lev-
els in controls but only low levels in mutants (Fig. 1E).
Moreover, BRG1 protein was readily detected by immu-
nofluorescence (IF) in controls but not mutants (Fig. 1F).
These results confirm that Brg1 gene product was sig-
nificantly depleted in mutant oocytes.
Cleavage-stage arrest of Brg1Zp3-Cre maternally
depleted embryos
To investigate whether the reduced reproductive perfor-
mance of Brg1Zp3-Cre females might be explained by an
embryonic phenotype, we bred Brg1Zp3-Cre and control
females to wild-type males and flushed two-cell embryos
out of oviducts on embryonic day 1.5 (E1.5). Brg1Zp3-Cre
females produced two-cell embryos that appeared nor-
mal (Fig. 2A,E), indicating that maternal Brg1 is not re-
quired for any aspect of oogenesis, including oocyte
growth, meiosis I, fertilization, or meiosis II. However,
embryo culture experiments revealed very few mater-
nally depleted embryos from Brg1Zp3-Cre females that de-
veloped to the blastocyst stage (Fig. 2A–D), whereas
nearly all of the embryos from control females did so
(Fig. 2E–H). The vast majority (88%) of maternally de-
pleted embryos were arrested in the early cleavage
stages, with 78% arresting at the two-cell stage and 10%
at the three- or four-cell stage (Fig. 2I). In contrast, only
3% of embryos from control females were arrested at
these cleavage stages (Fig. 2I).
The relevant genetic difference between the two
classes of embryos cultured in Figure 2, A– D compared
with Figure 2, E–H, was the genotype of their mothers’
germlines (i.e., maternal genotype). Maternally depleted
embryos had a maternal genotype of Brg1−/− and a
zygotic genotype of Brg1+/−, whereas controls had a
maternal genotype of Brg1+/− and a zygotic genotype
of either Brg1+/+ or Brg1+/− (there was no phenotypic
difference between these two control subclasses).
Figure 1. Analysis of Brg1Zp3-Cre mutant germline.
(A,B) H&E-stained ovary sections from wild-type con-
trol (A) and conditional mutant (B) females at 100×
magnification. Primary follicles (arrowheads), second-
ary follicles (arrows) follicles, and corpora lutea (*) are
indicated. (C) Average number of unfertilized eggs re-
covered from superovulated wild-type control (C) and
conditional mutant (M) females. (D) DIC (top) and DAPI
(bottom) images of wild-type control (C) and condi-
tional mutant (M) ovulated eggs at 400× magnification.
Polar bodies and MII-arrested chromosomes are visible
in DIC and DAPI images, respectively. (E,F) Brg1 gene
product is depleted in unfertilized eggs from condi-
tional mutant females. (E) Image of ethidium bromide
stained agarose gel containing -actin (1020 base pairs
[bp]) and Brg1 (585 bp) RT–PCR products. (MW) One-
kilobase ladder molecular-weight standard; (+) positive
control consisting of wild-type neonatal tissues; (−),
negative control consisting of wild-type neonatal tis-
sues except reverse transcriptase was omitted from RT
reaction; (C) 20 unfertilized eggs from wild-type con-
trol; (M) 20 unfertilized eggs from conditional mutant.
(F) IF of BRG1 protein in unfertilized eggs from wild-
type control (C) or conditional mutant (M) females. DIC
images are shown to the right.
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Therefore, Brg1Zp3-Cre is clearly a maternal-effect muta-
tion.
In our initial embryo culture experiments, as described
above, 12% of the maternally depleted embryos did not
arrest at the two- to four-cell stage but advanced to the
blastocyst stage. The timing of the floxed-to-floxed re-
combination event might explain the presence of these
“escapers.” Zp3-Cre and Brg1 are both transcribed dur-
ing the oocyte growth phase (Pan et al. 2005). Therefore,
Cre must be transcribed and translated, enter the
nucleus, and mediate recombination of the Brg1 floxed
allele before Brg1 mRNA reaches appreciable levels. It
was our hypothesis that enough Brg1 gene product is
synthesized to be functional in 12% of mutant oocytes.
To test this hypothesis, we repeated the embryo culture
experiments with a second Brg1Zp3-Cre stock lacking a
NLS in the transgene (de Vries et al. 2000). The predic-
tion was that, without a NLS, Cre would not enter the
nucleus as efficiently, recombination would occur later
during oocyte development, maternal Brg1 mRNA levels
would surpass a critical threshold in a higher percentage
of eggs, and more embryos would escape the two-cell
arrest. This prediction proved correct as ∼50% of em-
bryos escaped the developmental arrest (Fig. 2J). Conse-
quently, all subsequent experiments were performed
with the Brg1Zp3-Cre stock containing the NLS since it
conferred a more highly penetrant phenotype.
Reduced transcription in maternally depleted embryos
Considering that Brg1Zp3-Cre females were bred to wild-
type males, all of the maternally depleted embryos had a
heterozygous genotype. To evaluate zygotic expression
of the wild-type paternal allele, which is normally ex-
pressed at the two-cell stage based on transcript-profiling
experiments (Zeng et al. 2004), we performed RT–PCR
on two-cell embryos. Brg1 mRNA was detected at robust
levels in control embryos but not detected in maternally
depleted embryos (Fig. 3A). This result suggests maternal
mRNA is degraded and replaced by zygotic transcripts in
control embryos but not maternally depleted embryos.
On the one hand, maternal BRG1 may regulate zygotic
Brg1 expression via an autoregulatory mechanism. On
the other hand, maternal BRG1 may not only regulate
zygotic Brg1 transcription but also regulate the tran-
scription of other genes as part of ZGA. The observed
cleavage-stage arrest is consistent with a ZGA defect be-
cause blocking embryonic transcription with -amanitin
does not prevent the one-to-two-cell transition but does
inhibit progression to the four-cell stage (Flach et al.
1982; Bolton et al. 1984; Schultz 1993).
The transcription-requiring complex (TRC) is an ac-
cepted marker for ZGA (Schultz 1993). Therefore, we
analyzed TRC synthesis and observed a marked reduc-
tion in maternally depleted embryos compared with con-
trol embryos (Fig. 3B). The expression of Spindlin (SPIN),
which is synthesized from maternal transcripts (Oh et al.
1997), was relatively unaffected and suggests that the
overall reduction in TRC synthesis was unlikely the re-
sult of reduced metabolism or poor viability.
Reduced levels of TRC synthesis suggested that the
major reprogramming of gene expression that occurs dur-
ing the two-cell stage did not occur properly in mater-
nally depleted embryos (i.e., genes that are normally ac-
tivated during this transition were not fully activated).
Consistent with this proposal, a cluster dendrogram re-
vealed that maternally depleted and control two-cell em-
bryos clustered separately (Supplementary Fig. S2), and
microarray analysis revealed 315 out of ∼1000 -amani-
tin-sensitive genes (Zeng and Schultz 2005) were down-
regulated by at least twofold in maternally depleted em-
bryos compared with controls (Supplementary Table S1).
This finding indicates that maternal BRG1 is a signifi-
cant transcriptional regulator during ZGA; at the same
time, however, BRG1 is not part of the core transcrip-
tional machinery since only a subset of genes are af-
fected. To validate the transcript profiling results, we
performed transcription run-on assays by monitoring
BrUTP incorporation in two-cell embryos as a measure
Figure 2. Cleavage-stage arrest of Brg1Zp3-Cre maternally de-
pleted embryos. (A–H) Representative bright-field photographs
from an embryo culture experiment. Maternally depleted (A)
and control (E) embryos were flushed out of oviducts at the
two-cell stage on E1.5. Maternally depleted (A–D) and control
(E–H) embryos were subsequently cultured for 1 d (equivalent of
E2.5) (B,F), 2 d (equivalent of E3.5) (C,G), or 3 d (equivalent of
E4.5) (D,H). Maternally depleted embryos remained at the two-
cell stage throughout the culture period (B–D). Control embryos
advanced to the uncompacted and compacted morula stages (F),
compacted morula and blastocyst stages (G), and expanded
blastocyst stage (H). Embryos came from control (Brg1+/floxed,
TgZp3-Cre) or Brg1Zp3-Cre females bred to wild-type males.
(I) Quantification of the two- to four-cell arrest in control
(C) and maternally depleted (M) embryos after the 3-d culture
period. Numbers of embryos cultured are indicated. (J) Quanti-
fication of the two- to four-cell arrest in embryos with a Zp3-
Cre transgene lacking a NLS after 3-d culture period. Numbers
of embryos cultured are indicated.
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of overall transcriptional activity. BrUTP incorporation
in maternally depleted embryos was reduced by ∼35%
compared with control embryos (Fig. 3C,D).
The list of down-regulated genes was subjected to Ex-
pression Analysis Systematic Explorer (EASE) analysis.
EASE facilitates interpreting gene lists derived from mi-
croarray experiments by providing statistical methods
(reported as an EASE score) for discovering biological
themes within gene lists. EASE unmasks biological
themes by identifying functional gene categories that are
overrepresented (Hosack et al. 2003). Overrepresentation
does not refer to the abundance of gene expression but
rather describes a class of functionally similar genes that
are enriched in a data set relative to a normal distribu-
tion of all genes assayed (Zeng et al. 2004).
EASE analysis revealed that genes involved in tran-
scription and RNA processing as well as cell cycle regu-
lation were preferentially overrepresented (Fig. 3E; for
gene list, see Supplementary Table S2). This finding is
provocative given the results of a previous study indicat-
ing genes of similar function were preferentially ex-
pressed during ZGA (Zeng et al. 2004).
A direct requirement for maternal Brg1 gene product
in the embryo
The cleavage-stage arrest could be a consequence of mis-
expression of Brg1-regulated genes during oocyte growth
and not reflect a direct role for BRG1 in ZGA per se.
However, it is unlikely deficiencies in oocyte gene ex-
pression patterns contribute significantly to the develop-
mental arrest observed at the two-cell stage. In support
of this notion, microinjection of wild-type zygotes with
Brg1 double-stranded RNA (dsRNA) resulted in ∼50% of
them arresting at the two- to four-cell stage (Fig. 4A).
Cleavage-stage development was unaffected in zygotes
injected with either GFP dsRNA or water as controls
(Fig. 4A). In addition, we noted a substantial reduction in
BRG1 protein levels treated with Brg1 dsRNA compared
with GFP dsRNA (Fig. 4B). Thus, depletion of maternal
BRG1 after oocyte development is complete phenocop-
ied the Brg1Zp3-Cre oocyte-specific mutation.
Normal and aberrant covalent histone modifications
Considering that SWI/SNF-related complexes and HATs
are recruited to promoters in a coordinated manner (Nar-
likar et al. 2002), a logical function for BRG1 in ZGA is
to regulate chromatin structure and, in particular, his-
tone modifications. To investigate a potential link be-
tween SWI/SNF-related complexes and HATs during
ZGA, we tested histone acetylation levels in Brg1Zp3-Cre
embryos. Pan-acetyl histone 4 (H4) levels, measured by
IF, showed no significant difference between maternally
depleted and control two-cell embryos (Fig. 5). Some
acetylated residues, including histone 4 Lys 8 (H4K8),
H4K12, and H4K16, are inversely correlated with tran-
scription (Kurdistani et al. 2004). Therefore, it remained
possible that overall acetylation levels were unchanged
due to a decrease in stimulatory marks balanced with an
increase in inhibitory marks. To test this hypothesis, we
analyzed the levels of acetyl H3K9 as it is a specific
stimulatory mark (Kurdistani et al. 2004). However,
similar to the pan-acetyl H4 results, this modification
was also unchanged (Fig. 5). These findings suggest that
BRG1 and SWI/SNF-related complexes do not act up-
stream of histone acetylation in the two-cell embryo.
The above experiments did not rule out a role for
BRG1 and SWI/SNF regulating another covalent histone
modification tightly correlated with transcriptional ac-
tivity, dimethyl H3K4 (Bernstein et al. 2002; Schneider
Figure 3. Reduced gene expression in Brg1Zp3-Cre maternally
depleted embryos. (A) Image of ethidium bromide-stained aga-
rose gel containing -actin (1020 bp) and Brg1 (585 bp) RT–PCR
products. (MW) One-kilobase ladder molecular-weight stan-
dard; (+) positive control consisting of wild-type neonatal tis-
sues; (−) negative control consisting of wild-type neonatal tis-
sues except reverse transcriptase was omitted from RT reaction;
(C) two-cell embryos from wild-type control female (n = 15); (M)
maternally depleted two-cell embryos (n = 15). (B) 35S-methio-
nine metabolic labeling of a pool of six control (C) and six ma-
ternally depleted (M) two-cell embryos. Shown is a representa-
tive autoradiograph of a polyacrylamide gel with molecular
weights (in kilodaltons) indicated at the left and the TRC and
SPIN proteins indicated at the right. (C) BrUTP incorporation
detected by IF as a measure of genome-wide transcription. Rep-
resentative confocal images of control (C, top) and maternally
depleted (M, bottom) two-cell embryos are shown. (Right pan-
els) DIC images are also shown. (D) Quantification of BrUTP
incorporation data. Relative intensity of control (C) and mater-
nally depleted (M) embryos. (E) EASE analysis of selected bio-
logical processes.
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et al. 2004). Interestingly, dimethyl H3K4 levels in ma-
ternally depleted embryos were significantly reduced
relative to controls (Fig. 5). Quantification of mean fluo-
rescent activity in optical slices captured by confocal
microscopy revealed that dimethyl H3K4 levels were re-
duced to ∼61% of normal in mutants (Fig. 5).
Treating maternally depleted embryos with tricho-
statin A (TSA), a histone deacetylase (HDAC) inhibitor,
from the one- to two-cell stage significantly increased
histone acetylation, dimethyl H3K4 levels, and tran-
scription (detected by BrUTP incorporation) but did not
overcome the two- to four-cell arrest (data not shown).
This result was anticipated because TSA interferes with
a chromatin-mediated transcriptionally repressive state
superimposed upon ZGA that silences numerous genes
transiently expressed during the two-cell stage. Accord-
ingly, TSA also blocks the development of wild-type em-
bryos beyond the two- to four-cell stage (Ma et al. 2001).
Discussion
Results described here demonstrate that Brg1 is a new
member of a small but growing list of mammalian ma-
ternal-effect genes. The basis for this conclusion is three-
fold: (1) A Brg1 oocyte-specific mutation has no apparent
effect on oocyte development, ovulation, or fertilization,
but results in a developmental arrest at the two-cell
stage. (2) Depletion of BRG1 subsequent to normal oo-
cyte development phenocopies the oocyte-specific mu-
tation. (3) Maternal BRG1 is required to successfully re-
program gene expression patterns during the two-cell
stage, and failure to reprogram the zygotic genome is
linked to decreased H3K4 methylation. Thus, maternal
BRG1 has a decisive embryonic function following oo-
cyte development.
Genetic screens in Drosophila have identified numer-
ous maternal-effect genes (Perrimon et al. 1989; Schup-
bach and Wieschaus 1989; Bellotto et al. 2002), and mo-
lecular characterization of the maternal gene products
support the notion that embryogenesis begins during oo-
genesis (Wolpert et al. 2002). The difficulty in conduct-
ing similar mutagenesis screens in mammals has made
identifying maternal-effect genes far more difficult. Nev-
ertheless, several maternal-effect genes have been iden-
tified in mice: Mater (maternal antigen that embryos re-
quire) (Tong et al. 2000), Hsf1 (heat-shock factor 1)
(Christians et al. 2000), Dnmt1o (DNA methyltransfer-
ase 1, oocyte isoform) (Howell et al. 2001), Npm2 (nu-
cleoplasmin 2) (Burns et al. 2003; De La Fuente et al.
2004), Stella (Payer et al. 2003), Zar1 (zygotic arrest 1)
(Wu et al. 2003), E-cadherin (de Vries et al. 2004), Pms2
(Gurtu et al. 2002), Ezh2 (enhancer of zeste 2) (Erhardt
Figure 5. Normal and aberrant covalent histone modifications.
Representative confocal images detecting covalent histone
modifications by IF in control (genotype of dam: floxed/floxed,
no transgene) and maternally depleted (Mutant) embryos. Anti-
pan-acetyl-H4 (top row), anti-acetyl-H3K9 (middle row), and
anti-dimethyl-H3K4 (bottom row) primary antibodies were uti-
lized. Signal is excluded from nucleoli (dark spots in center).
The small, bright spots corresponding to neither nucleus in the
top right and bottom left panels are polar bodies. Quantification
of the IF data in control (C) and maternally depleted (M) em-
bryos is shown furthest to the right under Relative Fluorescence
heading.
Figure 4. Perturbation of BRG1 by RNAi re-
sults in cleavage-stage arrest and reduced pro-
tein levels. (A) Quantification of two- to four-
cell arrest after wild-type zygotes were in-
jected with water (ddH2O), dsGFP RNA, or
dsBrg1 RNA and cultured for 4 d. Numbers of
zygotes injected are indicated. (B) Representa-
tive confocal images detecting BRG1 protein
by IF in three-cell embryos injected with
dsGPF (top) or dsBrg1 (bottom) RNAs. BRG1
protein is nuclear but excluded from nucleoli
(dark spots). Only one nucleus is visible in
optical slice shown for the dsGFP panel; the
other two nuclei express similar levels of
BRG1 protein as shown in Supplementary
Figure S3. In contrast, all three nuclei are in
optimal focal plane for dsBrg1 panel. DIC im-
ages are shown to the right.
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et al. 2003), Dnmt3a (DNA methyltransferase 3A) (Ka-
neda et al. 2004), and mHR6A (RAD6-related) (Roest
et al. 2004).
Apart from Brg1, E-cadherin, Pms2, Ezh2, Dnmt3a,
and mHR6A, all of these maternal-effect genes are ex-
pressed exclusively in oocytes. In addition, only Mater
and mHR6A mutants confer the same phenotype (i.e.,
two-cell arrest) as BRG1 maternally depleted embryos.
The other mutants arrest primarily at the one-cell stage
(Npm2, Stella, Zar1, Hsf1), during later stages of preim-
plantation (Stella, Pms2), or during post-implantation
(Dnmt3a, Dnmt1o) development; exhibit a postnatal
phenotype (Ezh2); or appear normal because of rescue
from the wild-type paternal allele (E-cadherin). More-
over, the underlying molecular basis for the developmen-
tal arrest of these various mutants is poorly defined. For
example, although Mater-deficient embryos arrest at the
two-cell stage and display reduced expression of the
TRC, the molecular mechanism underlying the pheno-
type has not been elucidated (Tong et al. 2004). Simi-
larly, mHR6A encodes a RAD6-like protein predicted to
have ubiquitin-conjugating activity, but methylation of
H3K4 was unaffected in mutants and transcription was
not analyzed (Roest et al. 2004).
In contrast to these other maternal-effect genes, re-
sults reported here point to a plausible molecular mecha-
nism that, when disrupted, gives rise to embryonic arrest
at the two-cell stage. ZGA entails a dramatic reprogram-
ming of gene expression that must be faithfully executed
in order for development to proceed. Whereas ZGA was
previously thought to be relatively promiscuous due to
the extensive chromatin remodeling, results of microar-
ray experiments demonstrate that genes involved in
transcription, RNA processing, and cell cycle regulation
are preferentially expressed (Zeng et al. 2004). What is of
particular interest is that expression of a restricted sub-
set of genes involved in these processes is preferentially
reduced in BRG1 maternally depleted two-cell embryos.
This failure to reprogram correctly likely underlies the
observed two-cell arrest.
The lack of functional compensation of brahma pro-
tein (BRM), which is also expressed in oocytes and is
75% identical to BRG1, is surprising. Maternal BRM
might have been expected to prevent cleavage-stage ar-
rest until after it is degraded at the four-cell stage (Le-
Gouy et al. 1998). Nevertheless, BRM may be compen-
sating to prevent a block in oocyte development. Evi-
dence to support such a compensatory function comes
from Drosophila, where perturbing the sole brahma gene
in the oocyte blocks oogenesis (Brizuela et al. 1994).
ZGA, by definition, must be initiated by maternally
derived proteins and/or mRNAs. The identity of such
maternally derived factors essential for ZGA, however,
has alluded identification until recently. Recruitment of
maternal cyclin A2 mRNA, in collaboration with CDK2,
appears to be a critical event because genome activation
is inhibited in the zygote when maternal cyclin A2
mRNA is targeted by an small interfering RNA (siRNA)
(Hara et al. 2005). Moreover, microinjection of recombi-
nant cyclin A2-CDK2 protein increases transcriptional
activity (Hara et al. 2005). Maternally derived BRG1 also
appears to be a critical component in the central process
of genome activation and, as such, is the first maternal
factor linked with expression of specific genes during
ZGA. Because the oocyte-specific mutation and Brg1
dsRNA perturb zygotic Brg1 expression, lack of zygotic
BRG1 may also contribute to the decreased transcrip-
tional state and developmental arrest. Our finding of de-
creased dimethyl H3K4 (a mark for transcriptionally ac-
tive chromatin) in BRG1-depleted embryos provides a
framework for understanding the molecular mechanism
of ZGA.
We propose a model outlining the relationship be-
tween maternally derived SWI/SNF-related complexes,
histone acetylation, and transcription during ZGA
(Fig. 6). The finding that H4 and H3K9 acetylation levels
are normal in BRG1 maternally depleted embryos sug-
gests SWI/SNF-related complexes act downstream of or
in parallel to HATs. In support of BRG1 “reading” acety-
lated histones, ChIP experiments have shown that tran-
scription factors can directly recruit HATs to promoters
of downstream target genes, and this, in turn, creates
docking sites for the BRG1 bromodomain and facilitates
binding of SWI/SNF-related complexes (Jacobson et al.
2000; Agalioti et al. 2002; Narlikar et al. 2002; Yang
Figure 6. A model depicting the relationship of SWI/SNF-re-
lated complexes and covalent histone modifications during
ZGA. Maternally derived SWI/SNF-related complexes (left) and
histone acetylation (right) converge to stimulate MLL. MLL
methylates H3K4, which, in turn, results in transcription. In
Brg1Zp3-Cre maternally depleted embryos, dimethyl H3K4 and
transcription are reduced but not abolished, because the histone
acetylation input is intact and other chromatin remodeling
complexes might compensate. For the same reason, TSA treat-
ment of maternally depleted embryos increases histone acety-
lation and restores dimethyl H3K4 to levels of untreated con-
trols and transcription to higher than normal levels nearly equal
to TSA-treated controls. It is also likely that histone acetylation
stimulates transcription in a dimethyl H3K4-independent man-
ner (line from Ac to transcription). (Ac) Acetyl group on N-
terminal tail of a core histone; (HAT) histone acetyltransferase;
(HDAC) histone deacetylase; (TSA) trichostatin A; (HMT) his-
tone methyltransferase; (MLL) mixed lineage leukemia.
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2004). Both BRG1-containing SWI/SNF complexes and
acetylation of core histones influence H3K4 methylation
patterns in the two-cell embryo. This conclusion is
based on the findings that BRG1 maternally depleted
embryos have reduced dimethyl H3K4 and increasing
histone acetylation levels in control or BRG1-depleted
embryos (via TSA treatment) increases dimethyl H3K4.
Both of these epigenetic mechanisms must influence di-
methyl H3K4 indirectly because neither one has meth-
yltransferase activity. Based on several lines of evidence,
we speculate that both SWI/SNF-related complexes and
histone acetylation affect mixed-lineage leukemia (MLL)
to increase dimethyl H3K4 during ZGA. First, MLL is a
histone methyltransferase that specifically methylates
H3K4 and is associated with transcriptional activity
(Milne et al. 2002; Nakamura et al. 2002). Second, SWI/
SNF-related complexes genetically and physically inter-
act will MLL (Dingwall et al. 1995; Rozenblatt-Rosen et
al. 1998; Milne et al. 2002; Nakamura et al. 2002). Third,
H3 acetylation stimulates MLL methyltransferase activ-
ity (Milne et al. 2002). Finally, an Mll truncation muta-
tion, which may have dominant-negative activity by in-
terfering with wild-type MLL protein in the oocyte, con-
fers two-cell arrest (Ayton et al. 2001). The mutant MLL
protein is predicted to lack the catalytic SET domain and
could compete with wild-type MLL protein for entry into
functional high-molecular-mass complexes. TSA treat-
ment of BRG1 maternally depleted embryos has a stron-
ger effect on acetylation and transcription than dimethyl
H3K4 levels, and this result suggests that acetylation can
also stimulate transcription in a dimethyl H3K4 inde-
pendent manner.
Identifying additional factors involved in ZGA will
provide further insight into how the genome is trans-
formed from a transcriptionally quiescent state at fertil-
ization to one that is robustly transcribed shortly there-
after. Consequently, we should gain a better understand-
ing of how the genome is reprogrammed such that the
restricted developmental potential of the highly differ-
entiated egg and sperm pronuclei is restored to the toti-
potent state of the cleavage-stage embryo. Such knowl-
edge may have implications in the field of cloning (i.e.,
somatic cell nuclear transfer) because a similar repro-
gramming event must occur following introduction of a
somatic nucleus into a recipient egg. In this regard, it is
noteworthy that BRG1 and ISWI chromatin remodeling
complexes are required to reprogram somatic nuclei of
differentiated cells (Kikyo et al. 2000; Hansis et al. 2004).
These data, together with the work presented here, im-
plicate BRG1 and chromatin remodeling as central play-




Mice were maintained on a mixed genetic background and geno-
typed for Brg1null, Brg1floxed, and the Zp3-Cre transgene as al-
ready described (Lewandoski et al. 1997; Sumi-Ichinose et al.
1997; Bultman et al. 2000).
Histology
Ovaries were dissected, fixed in 4% paraformaldehyde, and pro-
cessed for the production of paraffin sections. Sections (5–8 µm)
were stained with H&E.
Embryo culture
According to standard procedures (Hogan et al. 1994), fertilized
eggs or two-cell embryos were flushed out of oviducts and cul-
tured in KSOM supplemented with amino acids (Specialty Me-
dia) in a 37°C incubator containing 5% CO2.
35S-methionine metabolic labeling
Two-cell embryos were metabolically radiolabeled with 35S-
methionine, and the radiolabeled proteins were resolved by
SDS-PAGE and detected by autoradiography as previously de-
scribed (Conover et al. 1991).
RNA extraction, labeling, and hybridization
Total RNA was extracted from 20 two-cell embryos, amplified,
labeled, and fragmented as previously described (Pan et al.
2005). Each embryo sample was collected from a single mouse,
and four separate samples were analyzed for each group. The
yield of biotinylated cRNA for each replicate was 45–70 µg, and
the RNA samples were submitted to the Penn Microarray Fa-
cility and hybridized to MOE430 version 2 GeneChips (Af-
fymetrix), which contain ∼39,000 transcripts that cover most of
the mouse genome. Quality-control parameters (e.g., percentage
present, 3:5 ratio) are found in Supplementary Table S3 and
indicate that the microarray data generated were of high quality.
Microarray data analyses
Microarray Analysis Suite 5.0 (MAS, Affymetrix) was used to
quantify microarray signals with default analysis parameters
and global scaling to target MEAN = 200. GeneChip tabular
data are available at the Gene Expression Omnibus repository
(http://www.ncbi.nlm.nih.gov/geo). The MAS metrics output
was loaded into GeneSpring version 7.2 (Silicon Genetics) with
per-chip normalization to the 50th percentile and per-gene nor-
malization to the median. Condition tree clustering was used to
identify relationships among the global gene expression levels
of samples. To minimize false positives, only the genes called as
“Present” in at least three out of four replicates for each treat-
ment group were used for Statistical Analysis of Microarrays
(SAM). Because four biological replicates provided sufficient sta-
tistical power and confidence levels to detect a 1.4-fold differ-
ence in RNA abundance (Zeng et al. 2004), genes with signifi-
cant differences of 1.4-fold or greater between conditions were
identified at a 5% false discovery rate using SAM. The resulting
gene lists were then imported into EASE (version 2.0) to analyze
the gene ontology for overrepresentation (Hosack et al. 2003).
The EASE score was calculated for likelihood of overrepresen-
tation of annotation classes and only selected biological pro-
cesses with an EASE score <5% are shown. Note that on the
Affymetrix Genechip used, each probe set represents one gene
but many Unigenes are represented more than once by different
probe sets.
RT–PCR
RT–PCR conditions for Brg1 have already been described (Bult-
man et al. 2000). The same conditions were utilized for -actin
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except the primer sequences (forward, 5-CAAGGTGTGATGG
TGGGAAT-3; reverse, 5-GGTGTAAAACGCAGCTCAGT-3).
RNAi
RNAi was performed as described (Svoboda et al. 2000; Wianny
and Zernicka-Goetz 2000). The Brg1 dsRNA corresponded to
nucleotides 2142–2734 of the cDNA sequence (Sumi-Ichinose
et al. 1997). The top (i.e., coding) strand of the dsRNA begins
with TCTGAGGTGGACGCCCGACACATTATTGAG and
ends with CACTGCAAGTTGACGCAGGTCCTTAACACA.
IF and BrUTP assays
For BRG1 IF, unfertilized eggs were fixed in chilled methanol,
washed three times in PBS, and blocked in 10% normal goat
serum in PBS. The primary antibody was a mouse monoclonal
(Santa Cruz Biotechnology) used at a 1:50 dilution. Samples
were washed three times in PBS, and a goat-anti-mouse second-
ary antibody conjugated to Alexa 594 (Molecular Probes) was
used at a 1:300 dilution. Following three additional washes in
PBS, samples were transferred to microdrops of Vectashield
mounting media (Vector Laboratories) in adhesive imaging
chambers (Schleicher & Schuell) sandwiched between glass cov-
erslips.
For the analysis of covalent histone modifications and BrUTP
incorporation by IF, one-cell embryos were recovered from am-
pullae at E0.5 and cultured in KSOM (Specialty Media) in the
presence or absence of 50 nM TSA (BIOMOL International)
overnight to the two-cell stage. For analysis of covalent histone
modifications, IF was performed as previously described (Sar-
mento et al. 2004). Primary antibodies were rabbit polyclonals
and diluted according to the manufacturer’s (Upstate) recom-
mendations. The secondary was a goat–anti-rabbit conjugated
to Alexa 594 (Molecular Probes) used at a 1:200 dilution.
BrUTP incorporation assays were performed as previously de-
scribed (Aoki et al. 1997). Briefly, the plasma membranes of
two-cell embryos were permeabilized for 1–2 min with 0.05%
Triton X-100 in physiological buffer (PB) that consisted of 100
mM potassium acetate, 30 mM KCl, 1 mM MgCl2, 10 mM
Na2HPO4, 1 mM ATP, 1 mM DTT, 0.2 mM PMSF, and 50 U/mL
of RNasin. Embryos were subsequently washed three times in
PB and transferred to transcription buffer consisting of 100 mM
potassium acetate, 30 mM KCl, 2 mM MgCl2, 10 mM
Na2HPO4, 2 mM ATP, and 0.4 mM each of GTP, CTP, and
BrUTP (Molecular Probes). Transcription reactions proceeded
for 10 min at 33°C, and the nuclear membranes were subse-
quently permeabilized for 3 min in PB containing 0.2% Triton
X-100. Embryos were then washed in PB three times and fixed
overnight in 4% paraformaldehyde at 4°C. Embryos were
washed and blocked through five changes of PBS containing
3 mg/mL BSA (PBS/BSA) and incubated for 45 min with a
mouse monoclonal antibody raised against BrdU (Boehringer-
Mannheim) diluted to 2 µg/mL in PBS/BSA. Embryos were
washed in PBS/BSA, incubated in a goat–anti-mouse secondary
antibody conjugated to FITC or Alexa 594 (Molecular Probes)
at a 1:300 dilution, washed again in PBS/BSA, and mounted in
Vectashield medium as described above.
Confocal microscopy and quantification of IF
IF was detected using a LSMJ confocal instrument (Carl Zeiss).
Focal planes with the greatest signal intensity were identified
by focusing through the entire egg or two-cell embryo, and com-
posite images representing the mean of four optical slices from
these most intense focal planes were saved. Nucleoli were evi-
dent as a dark center surrounded by a ring of fluorescence in
images of covalent histone modifications. The nucleoli served
as landmarks to confirm that similar focal planes were being
compared in controls and mutants. Quantification was per-
formed using NIH Image J software (National Institutes of
Health). Briefly, nuclear signal was outlined and mean fluores-
cence intensity was measured. This same encircled region was
dragged to the cytoplasm of the same cell, and background fluo-
rescence was measured. Specific signal was calculated by divid-
ing nuclear values by cytoplasmic values. The mean of un-
treated controls was set as 100% relative fluorescent intensity.
Treated controls as well as untreated and treated mutants were
expressed relative to untreated controls. Standard deviations
were calculated and are represented by error bars.
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